Literature DB >> 1089403

Intravitreal injection of cephaloridine in the treatment of endophthalmitis.

R O Graham, G A Peyman, G Fishman.   

Abstract

Ocular toxic effects of intravitreal injection of cephaloridine in rabbits was evaluated, and none were produced in doses of 0.25 mg or less. Clinically, intravitreal injection of cephaloridine in doses of 5 mg or more produced small punctate hemorrhages in the vascularized portions of the rabbit retina within two days. With doses of 2.5 mg or less, no clinical changes were seen during the two weeks of observation. Histologically, one day following intravitreal injection of 0.5 to 10 mg of cephaloridine there was clumping of the outer segments of the photoreceptors and destruction of the retinal pigment epithelium. Ten milligrams of cephaloridine intravitreally injected caused definite electroretinogram (ERG) changes ten minutes after injection. After 24 hours, the ERG was extinguished. An experimentally induced Escherichia coli endophthalmitis was successfully treated after six hours by intravitreal injection of cephaloridine.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1089403     DOI: 10.1001/archopht.1975.01010020060011

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  5 in total

1.  Lincomycin by direct intravitreal injection in the treatment of experimental bacterial endophthalmitis.

Authors:  A G Schenk; G A Peyman
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1974

Review 2.  Factors affecting the efficacy of antibiotics in the treatment of experimental postoperative endophthalmitis.

Authors:  G A Stern
Journal:  Trans Am Ophthalmol Soc       Date:  1993

3.  The experimental and clinical use of intravitreal antibiotics to treat bacterial and fungal endophthalmitis.

Authors:  G A Peyman; D W Vastine; H I Meisels
Journal:  Doc Ophthalmol       Date:  1975-11-21       Impact factor: 2.379

4.  Retinal toxicity of antibiotics: evaluation by electroretinogram.

Authors:  K Mochizuki; M Torisaki; K Kawasaki; Y Shirao; Y Yamashita; K Kitano; D Yonemura
Journal:  Doc Ophthalmol       Date:  1988-06       Impact factor: 2.379

5.  Intravitreal penetration of oral pefloxacin in humans.

Authors:  M Oncel; G A Peyman
Journal:  Int Ophthalmol       Date:  1993-08       Impact factor: 2.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.